相关实验视频

Updated: Sep 16, 2025

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

瘤性YAP通过CDK4/6驱动的G1加速使细胞对CHK1抑制敏感

Dörthe Gertzmann¹, Cornelius Presek¹, Anna Lena Mattes¹

¹Department of Biochemistry and Cell Biology, Theodor Boveri Institute, Biocenter, Julius Maximilian University Würzburg, Am Hubland, 97074, Würzburg, Germany.

|July 4, 2025

概括

瘤性YAP通过缩短G1阶段导致复制应激,从而导致DNA损伤. 用CHK1抑制剂准这种脆弱性为依赖YAP的癌症提供了潜在的治疗策略.

科学领域:

细胞生物学细胞生物学
分子生物学分子生物学
癌症研究癌症研究

背景情况:

复制压力驱动基因组不稳定性和癌症,通过引起DNA损伤和突变.
河马信号通路的联合激活器,YAP,调节细胞生长和分化,但其在产生可用于治疗的复制应激中的作用尚不清楚.

研究的目的:

调查瘤性YAP是否会产生可用于治疗的复制应激.
阐明YAP诱导复制应激的机制,并确定潜在的治疗漏洞.

主要方法:

在表达瘤性YAP的细胞中分析细胞周期进展和DNA复制动态.
在YAP表达细胞中评估DNA损伤和对CHK1抑制的敏感性.
研究YAP-TEAD相互作用,转录和转录复制冲突 (TRCs) 在YAP诱导的复制压力中的作用.

主要成果:

瘤性YAP通过CDK4/6缩短G1阶段,导致S阶段的早期进入,原产地低许可,并加速复制分叉速度.
在YAP表达细胞中抑制CHK1导致S相DNA损伤,这取决于YAP-TEAD相互作用,全球转录增加和TRCs升高.
可以通过恢复G1长度或减少YAP驱动的超转录来缓解YAP诱导的复制压力.

结论:

瘤性YAP诱导一种独特的复制压力形式,其特点是加速复制叉速度和增加的转录-复制冲突.
通过利用它们对复制应激的脆弱性,特别是通过CHK1抑制或转录调节来准依赖YAP的癌细胞,呈现出一个有前途的治疗途径.

关键词:

在CDK4/6中使用.一个瑞士克朗.复制压力复制压力哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈

更多相关视频

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols

Published on: June 6, 2017

Temporal Tracking of Cell Cycle Progression Using Flow Cytometry without the Need for Synchronization

Temporal Tracking of Cell Cycle Progression Using Flow Cytometry without the Need for Synchronization

Published on: August 16, 2015

相关概念视频

Inhibition of Cdk Activity

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...

DNA Damage can Stall the Cell Cycle

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...

M-Cdk Drives Transition Into Mitosis

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...

Positive Regulator Molecules

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.

Negative Regulator Molecules

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.